BIOMARKER COMPOSITION FOR DIAGNOSIS OF SYSTEMIC LUPUS ERYTHEMATOSUS COMPRISING AIMP1 AND METHOD FOR DIAGNOSING SYSTEMIC LUPUS ERYTHEMATOSUS USING SAME

摘要

The present invention relates to a biomarker composition for diagnosis of SLE comprising AIMP1 as an active ingredient, and a method for diagnosing SLE using the same. Specifically, provided in the present invention are a biomarker composition for diagnosis of SLE comprising AIMP1, an SLE diagnosis kit using the same, and a method for diagnosing SLE. Also, provided is a biomarker composition for predicting a prognosis of SLE comprising AIMP1 as an active ingredient, a SLE prognosis prediction kit using the same, and a SLE prognosis prediction method. Therefore, the AIMP1 of the present invention can be effectively used for diagnosis and prognosis prediction of SLE.